Operating Income (Loss) of IR-Med, Inc. from 30 Sep 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IR-Med, Inc. quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Sep 2020 to 30 Jun 2025.
  • IR-Med, Inc. Operating Income (Loss) for the quarter ending 30 Jun 2025 was $286,000, a 20% increase year-over-year.
  • IR-Med, Inc. Operating Income (Loss) for the twelve months ending 30 Jun 2025 was $1,464,000, a 58% increase year-over-year.
  • IR-Med, Inc. annual Operating Income (Loss) for 2024 was $1,941,000, a 60% increase from 2023.
  • IR-Med, Inc. annual Operating Income (Loss) for 2023 was $4,911,000, a 3.1% decline from 2022.
  • IR-Med, Inc. annual Operating Income (Loss) for 2022 was $4,762,000, a 30% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

IR-Med, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,464,000 $286,000 +$72,000 +20% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,536,000 $253,000 +$405,000 +62% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,941,000 $324,000 +$938,000 +74% 01 Oct 2024 31 Dec 2024 10-K 04 Apr 2025 2024 FY
Q3 2024 $2,879,000 $601,000 +$596,000 +50% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $3,475,000 $358,000 +$742,000 +67% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $4,217,000 $658,000 +$694,000 +51% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $4,911,000 $1,262,000 +$800,000 +39% 01 Oct 2023 31 Dec 2023 10-K 04 Apr 2025 2024 FY
Q3 2023 $5,711,000 $1,197,000 -$321,000 -37% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $5,390,000 $1,100,000 -$129,000 -13% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $5,261,000 $1,352,000 -$499,000 -58% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $4,762,000 $2,062,000 -$1,056,000 -105% 01 Oct 2022 31 Dec 2022 10-K/A 08 Apr 2024 2023 FY
Q3 2022 $3,706,000 $876,000 -$154,000 -21% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $3,552,000 $971,000 +$545,000 +36% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $4,097,000 $853,000 -$422,000 -98% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $3,675,000 $1,006,000 01 Oct 2021 31 Dec 2021 10-K/A 11 May 2023 2022 FY
Q3 2021 $722,000 -$642,000 -802% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $1,516,000 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $431,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 $80,000 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3

IR-Med, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,941,000 +$2,970,000 +60% 01 Jan 2024 31 Dec 2024 10-K 04 Apr 2025 2024 FY
2023 $4,911,000 -$149,000 -3.1% 01 Jan 2023 31 Dec 2023 10-K 04 Apr 2025 2024 FY
2022 $4,762,000 -$1,087,000 -30% 01 Jan 2022 31 Dec 2022 10-K/A 08 Apr 2024 2023 FY
2021 $3,675,000 -$2,945,000 -403% 01 Jan 2021 31 Dec 2021 10-K/A 11 May 2023 2022 FY
2020 $730,000 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.